This bill requires Medicaid to cover medically necessary ovulation enhancing drugs and related medical services for individuals aged 21 to 44 who are experiencing infertility. The coverage includes expenses for office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing, with a limit of three treatment cycles per beneficiary's lifetime. Infertility is defined as the inability to conceive after 12 months of unprotected intercourse for individuals aged 21 to 34, or after six months for those aged 35 to 44. The bill amends Section 6 of P.L.1968, c.413 (C.30:4D-6) by adding a new subsection that outlines this coverage, contingent upon federal financial participation.

To facilitate the implementation of these changes, the bill empowers the Commissioner of Human Services to apply for necessary state plan amendments or waivers and to adopt rules and regulations as needed. The act is set to take effect four months after its enactment, although preparatory administrative actions may be initiated prior to that date. This legislation aims to improve access to fertility treatments for eligible individuals under the Medicaid program, addressing a critical healthcare need.

Statutes affected:
Introduced: 30:4D-6